FDA Inspection 1183800 — Labryo Fertility Center
The FDA completed an inspection of Labryo Fertility Center on October 25, 2022 in Newport Beach, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 25, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Newport Beach, CA (United States)